Whitehawk Therapeutics, Inc.
WHWK
$2.18
-$0.08-3.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -70.61% | 411.20% | |||
| Gross Profit | 70.61% | -1,931.17% | |||
| SG&A Expenses | -12.44% | -53.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -64.30% | 144.82% | |||
| Operating Income | 64.30% | -259.76% | |||
| Income Before Tax | 66.27% | -172.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 66.27% | -172.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 66.27% | -172.06% | |||
| EBIT | 64.30% | -259.76% | |||
| EBITDA | 64.30% | -261.01% | |||
| EPS Basic | 66.33% | -141.35% | |||
| Normalized Basic EPS | 66.66% | -109.23% | |||
| EPS Diluted | 65.86% | -141.62% | |||
| Normalized Diluted EPS | 66.66% | -110.81% | |||
| Average Basic Shares Outstanding | 0.18% | 74.27% | |||
| Average Diluted Shares Outstanding | 0.18% | 73.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||